Literature DB >> 7752661

Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents.

J J Lynch1, E P Baskin, E M Nutt, P J Guinosso, T Hamill, J J Salata, C M Woods.   

Abstract

Saturation binding studies in guinea pig ventricular myocytes with 3H-dofetilide, a radioligand for the cardiac rapidly activating delayed rectifier K+ IKr channel, indicated specific high-affinity binding with a Kd of 83 nM and a Bmax of 0.18 pmol/mg cellular protein (1.36 x 10(6) sites/cell). Using displacement of high-affinity 3H-dofetilide binding as a measure of interaction with the IKr channel, potencies (Ki values) for binding to the IKr channel in guinea pig myocytes for six class III antiarrhythmic agents were characterized and compared to indices of functional electrophysiologic activity in isolated guinea pig papillary muscles [EC25 values, concentration required to increase effective refractory period (ERP) 25% above baseline]. Dofetilide, E-4031, sematilide, and d-sotalol, which have been characterized previously as selective IKr blockers, displayed good agreement between Ki values for displacement of 3H-dofetilide binding (47 +/- 7 nM, 38 +/- 8 nM, 12 +/- 5 microM, and approximately 100 microM, respectively) and EC25 values for increasing ERP in papillary muscles (45.0 nM, 76.9 nM, 20.2 microM and 63.5 microM, respectively). Ibutilide and RP58866, which have been reported to act via mechanisms other than IKr block, had Ki values for displacement of 3H-dofetilide binding (16 +/- 7 nM and 17 +/- 2 nM, respectively) that were approximately 10-fold lower than EC25 values for increasing ERP in papillary muscles (185.8 nM and 223.5 nM, respectively). The potent displacement of high-affinity 3H-dofetilide binding by ibutilide and RP58866 strongly suggest a role for interaction with IKr in their actions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752661     DOI: 10.1097/00005344-199502000-00021

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

Review 1.  Dofetilide: a review of its use in atrial fibrillation and atrial flutter.

Authors:  K J McClellan; A Markham
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 2.  Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation.

Authors:  R H Foster; M I Wilde; A Markham
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

3.  Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle.

Authors:  N Oshikawa; I Watanabe; R Masaki; A Shindo; T Kojima; S Saito; Y Ozawa; K Kanmatsuse
Journal:  J Interv Card Electrophysiol       Date:  2001-03       Impact factor: 1.900

4.  Effects of sodium channel blockade on ibutilide induced prolongation of repolarization in the isolated rabbit ventricle.

Authors:  M A Wood; I Fuller; A Hong
Journal:  J Interv Card Electrophysiol       Date:  2000-10       Impact factor: 1.900

5.  Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.

Authors:  M A Vos; S R Golitsyn; K Stangl; M Y Ruda; L V Van Wijk; J D Harry; K T Perry; P Touboul; G Steinbeck; H J Wellens
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 6.  Current treatment recommendations in antiarrhythmic therapy.

Authors:  I C Van Gelder; J Brügemann; H J Crijns
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

7.  Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes.

Authors:  Ralph F Bosch; Alexander C Schneck; Saskia Csillag; Bernd Eigenberger; Uwe Gerlach; Joachim Brendel; Hans J Lang; Christian Mewis; Heinz Gögelein; Ludger Seipel; Volker Kühlkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-11       Impact factor: 3.000

8.  Chlorthalidone inhibits the KvLQT1 potassium current in guinea-pig ventricular myocytes and oocytes from Xenopus laevis.

Authors:  C Mancilla-Simbro; A López; E Martinez-Morales; E Soto-Perez-de-Celis; L Millan-PerezPeña; R Tsushima; E M Salinas-Stefanon
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

9.  Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.

Authors:  Anikó Kovács; János Magyar; Tamás Bányász; Péter P Nánási; Gábor Szénási
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  The Basis for Low-affinity hERG Potassium Channel Block by Sotalol.

Authors:  Yi Hong Zhang; Christopher E Dempsey; Jules C Hancox
Journal:  J Pharmacol Pharmacother       Date:  2017 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.